ArticleOncotarget2016

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation.

Jean Claude Chomel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.